[HTML][HTML] Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks
The Kelch-like ECH-associated protein 1/nuclear factor erythroid-derived 2-like 2
(KEAP1/NRF2) pathway is well recognized as a key regulator of redox homeostasis …
(KEAP1/NRF2) pathway is well recognized as a key regulator of redox homeostasis …
HIF1, HSF1, and NRF2: oxidant-responsive trio raising cellular defenses and engaging immune system
AM Cyran, A Zhitkovich - Chemical research in toxicology, 2022 - ACS Publications
Cellular homeostasis is continuously challenged by damage from reactive oxygen species
(ROS) and numerous reactive electrophiles. Human cells contain various protective systems …
(ROS) and numerous reactive electrophiles. Human cells contain various protective systems …
[HTML][HTML] Pan-cancer proteogenomics connects oncogenic drivers to functional states
Cancer driver events refer to key genetic aberrations that drive oncogenesis; however, their
exact molecular mechanisms remain insufficiently understood. Here, our multi-omics pan …
exact molecular mechanisms remain insufficiently understood. Here, our multi-omics pan …
Systematic discovery of protein interaction interfaces using AlphaFold and experimental validation
Structural resolution of protein interactions enables mechanistic and functional studies as
well as interpretation of disease variants. However, structural data is still missing for most …
well as interpretation of disease variants. However, structural data is still missing for most …
Versatile electrochemical biosensor based on the target-controlled capture and release of DNA nanotubes for the ultrasensitive detection of multiplexed biomarkers
L Kong, Z Han, M Zhao, X Zhang, Y Zhuo… - Analytical …, 2022 - ACS Publications
Herein, an ultrasensitive and versatile electrochemical biosensor was developed through
the target-controlled capture and release of signal probe-loaded DNA nanotube for the …
the target-controlled capture and release of signal probe-loaded DNA nanotube for the …
An “off-on-off” type electrochemical biosensor for detecting multiple biomarkers with DNAzyme-mediated entropy-driven catalytic and DSN enzyme-assisted recycling …
H Yang, Q Dong, D Xu, X Feng, P He, W Song… - Analytica Chimica …, 2023 - Elsevier
In this work, an intelligent and versatile electrochemical biosensor was constructed to detect
two types of biomarkers by utilizing “off-on-off” switching. Firstly, human apurinic/apyrimidinic …
two types of biomarkers by utilizing “off-on-off” switching. Firstly, human apurinic/apyrimidinic …
[HTML][HTML] The promising application of cell-cell interaction analysis in cancer from single-cell and spatial transcriptomics
Cell-cell interactions instruct cell fate and function. These interactions are hijacked to
promote cancer development. Single-cell transcriptomics and spatial transcriptomics have …
promote cancer development. Single-cell transcriptomics and spatial transcriptomics have …
[HTML][HTML] Exploring the dynamic links, implications for hedging and investment strategies between Sukuk and commodity market volatility: Evidence from country level …
This research paper examines the influence of spillovers between volatility of commodities
(including soft commodities, precious metals, industrial metals, along with energy) and …
(including soft commodities, precious metals, industrial metals, along with energy) and …
Extrapolating Lessons from Targeted Protein Degradation to Other Proximity-Inducing Drugs
GE Winter - ACS Chemical Biology, 2024 - ACS Publications
Targeted protein degradation (TPD) is an emerging pharmacologic strategy. It relies on
small-molecule “degraders” that induce proximity of a component of an E3 ubiquitin ligase …
small-molecule “degraders” that induce proximity of a component of an E3 ubiquitin ligase …
GSTO1 aggravates EGFR-TKIs resistance and tumor metastasis via deglutathionylation of NPM1 in lung adenocarcinoma
N Shen, M Luo, W Gu, M Gong, H Lei, L Bi, C Wang… - Oncogene, 2024 - nature.com
Despite significantly improved clinical outcomes in EGFR-mutant lung adenocarcinoma, all
patients develop acquired resistance and malignancy on the treatment of EGFR tyrosine …
patients develop acquired resistance and malignancy on the treatment of EGFR tyrosine …